128 related articles for article (PubMed ID: 33904146)
1. Targeting HIF-1α by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression.
Al-Ostoot FH; Sherapura A; V V; Basappa G; H K V; B T P; Khanum SA
Pharmacol Rep; 2021 Oct; 73(5):1328-1343. PubMed ID: 33904146
[TBL] [Abstract][Full Text] [Related]
2. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
3. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression.
Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT
Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496
[TBL] [Abstract][Full Text] [Related]
4. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
6. The Novel 4-Phenyl-2-Phenoxyacetamide Thiazoles modulates the tumor hypoxia leading to the crackdown of neoangiogenesis and evoking the cell death.
Mohammed YHE; Malojirao VH; Thirusangu P; Al-Ghorbani M; Prabhakar BT; Khanum SA
Eur J Med Chem; 2018 Jan; 143():1826-1839. PubMed ID: 29133037
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α.
Nepal M; Choi HJ; Choi BY; Kim SL; Ryu JH; Kim DH; Lee YH; Soh Y
Eur J Pharmacol; 2012 Sep; 691(1-3):28-37. PubMed ID: 22760073
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
9. Steroidal alkaloid solanidine impedes hypoxia-driven ATM phosphorylation to switch on anti-angiogenesis in lung adenocarcinoma.
Sherapura A; Siddesh BM; Malojirao VH; Thirusangu P; Avin BRV; Kumari NS; Ramachandra YL; Prabhakar BT
Phytomedicine; 2023 Oct; 119():154981. PubMed ID: 37531902
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
Park JJ; Hwang SJ; Park JH; Lee HJ
Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
[TBL] [Abstract][Full Text] [Related]
12. Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects.
Sapra P; Kraft P; Pastorino F; Ribatti D; Dumble M; Mehlig M; Wang M; Ponzoni M; Greenberger LM; Horak ID
Angiogenesis; 2011 Sep; 14(3):245-53. PubMed ID: 21452059
[TBL] [Abstract][Full Text] [Related]
13. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
[TBL] [Abstract][Full Text] [Related]
14. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
16. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
18. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
[TBL] [Abstract][Full Text] [Related]
19. A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1α signal transduction.
Kim KH; Jung HJ; Kwon HJ
Biochem Biophys Res Commun; 2013 Nov; 441(2):399-404. PubMed ID: 24161739
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ehrlich ascites cancer, hypoxia-inducible factor-1 alpha, and the kinase insert domain-containing receptor/
Madhu LN; Telkar S; Kamath D; D Souza ME; Rao S; Nayak PS; Sarojini BK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S74-S81. PubMed ID: 33380656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
